Trials / Recruiting
RecruitingNCT05321316
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with urothelial carcinoma, especially in patients with recurrent or advanced bladder cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-FDG | All study participants will undergo one 18F-FDG PET/CT scan. |
Timeline
- Start date
- 2026-05-31
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2022-04-11
- Last updated
- 2026-03-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05321316. Inclusion in this directory is not an endorsement.